MyAverix Finance
SW · Healthcare
Newron Pharmaceuticals SpA (NWRN)
Biotechnology
Newron Pharmaceuticals SpA (NWRN) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $292.11M, P/E ratio is 25.00, net margin is -69.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NWRN
Newron Pharmaceuticals SpA (NWRN) — FAQ
What is Newron Pharmaceuticals SpA's market cap?
Newron Pharmaceuticals SpA (NWRN) has a reported market cap of $292.11M (data as of 2026-05-24).
What is NWRN's P/E ratio?
The price-to-earnings (P/E) ratio for Newron Pharmaceuticals SpA (NWRN) is 25.00 (data as of 2026-05-24).
Does Newron Pharmaceuticals SpA pay a dividend?
Dividend yield is not available in the current snapshot for Newron Pharmaceuticals SpA (NWRN). Check the MyAverix Finance app for the latest dividend data.
What sector is Newron Pharmaceuticals SpA in?
Newron Pharmaceuticals SpA (NWRN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NWRN listed on?
NWRN is listed on SW.
What is Newron Pharmaceuticals SpA's net margin?
Newron Pharmaceuticals SpA (NWRN) reports a net margin of -69.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.